Combination of HDAC and FYN Inhibitors in Synovial Sarcoma Treatment
Date
2-20-2025
Faculty Mentor
Le Su, Biology
Files
Submission Type
Conference Proceeding
Location
9:00-9:10 am | Houston Cole Library, 11th Floor
Description
Synovial sarcoma is a deadly type of cancer that affects mainly children and young adults. It is a rare cancer and impacts 1 of 1000 individuals a year. It is very aggressive and deadly type of cancer with a 50% metastasis rate. Most patients that have synovial sarcoma live about two years or less after diagnosis. This presentation showcases how the combination of two clinically studied drugs are being used to find a drug synergy that can combat synovial sarcoma.
Keywords
student research, biology
Rights
This content is the property of Jacksonville State University and is intended for non-commercial use. Video and images may be copied for personal use, research, teaching or any "fair use" as defined by copyright law. Users are asked to acknowledge Jacksonville State University. For more information, please contact digitalcommons@jsu.edu.
Disciplines
Biology
Recommended Citation
Parker, Kyra, "Combination of HDAC and FYN Inhibitors in Synovial Sarcoma Treatment" (2025). JSU Student Symposium 2025. 34.
https://digitalcommons.jsu.edu/ce_jsustudentsymp_2025/34
